News & Updates
Filter by Specialty:
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
For pregnant women with HIV who are receiving dolutegravir (DTG)-based therapies, the two-drug regimen works just as well as three-drug regimens at keeping the viral load to "undetectable" levels without exerting serious adverse effects on neonatal outcomes, according to a study presented at HIV Glasgow 2022 Congress.
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
07 Nov 2022
Foetoplacental factors predict hypertension in early childhood
Foetal growth deceleration and high foetoplacental vascular resistance both contribute to an increased risk of prehypertension and hypertension in children, a study has found.
Foetoplacental factors predict hypertension in early childhood
05 Nov 2022
TNF inhibition beyond 24 weeks: How safe in pregnant mums?
Continued treatment with tumor necrosis factor (TNF) inhibitors after 24 weeks of pregnancy appears safe and is associated with lower chances of maternal inflammatory bowel disease (IBD) relapse, without increasing adverse neonatal outcomes, new research suggests.
TNF inhibition beyond 24 weeks: How safe in pregnant mums?
02 Nov 2022
Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
Using a lower glycaemic threshold led to more diagnoses of gestational diabetes, though its impact on maternal and birth outcomes remains uncertain, results of the GEMS* trial showed.
Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
01 Nov 2022
Dog owners ward off asthma against risk allele carriers
Among individuals carrying the 17q12-21 asthma-risk variant rs2305480, owning a dog appears to exert a protective effect against persistent wheeze, a recent study has found.